ArticleCJC open2026

Long-Term Follow-Up After Discontinuation of Mavacamten in Hypertrophic Obstructive Cardiomyopathy.

Mengdi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.